Early Discontinuation of Trastuzumab Adjuvant Chemotherapy in Breast Cancer Patients is Associated with both Cancer Treatment-Related Cardiovascular Toxicity and Mortality.
Early Discontinuation of Trastuzumab Adjuvant Chemotherapy in Breast Cancer Patients is Associated with both Cancer Treatment-Related Cardiovascular Toxicity and Mortality.
复制标题
乳腺癌患者早期停止曲妥珠单抗辅助化疗与癌症治疗相关的心血管毒性和死亡率相关。
DOI：
--
复制
发表时间：
2022
期刊：
影响因子：
--
通讯作者：
Ueda S.
中科院分区：
文献类型：
--
作者：
Miyazato K;Ohtsu H;Yonemoto N;Sase K;Ueda S.
